Why is "Generic drugs" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-26 21:39:31
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
A generic drug is a pharmaceutical drug that contains the same chemical substance as a proprietary drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance compared to their performance at the time when they were patented drugs. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Generic Drugs Head to the Supreme Court - Tradeoffs
-
The FDA Often Doesn’t Test the Quality of Generic Drugs, So We Did - ProPublica
-
Investigation raises concerns about lack of FDA quality testing for generic drugs - PBS
-
Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk - CNBC
-
Common Ownership May Reduce the Entry of Cheaper Generic Drugs - promarket.org
-
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application - Yahoo Finance
-
Nonprofits Are Ready to Repurpose Generic Drugs - Petrie-Flom Center
-
Securing a Healthier Future Through Generic Drugs - RealClearMarkets
-
From Concept to Policy: Pull Funding for Repurposed Generic Drugs - Margolis Institute for Health Policy
-
FDA Recall of Blood Pressure Pills Due to Cancer-Causing Contaminant May Point to Higher Safety Risks in Older Generic Drugs - UConn Today
-
Generic Drugs Are Attracting Federal Scrutiny And Action - Forbes
-
To Reshore Generic Drugs, Use Sugar’s Sweet Model - Coalition For A Prosperous America
-
Generic Competition and Drug Prices - fda.gov
-
INVESTIGATING GENERICS: Push for Safer Generic Drugs Picks Up Speed on Capitol Hill - MedShadow Foundation
-
Four Key Aspects of Generic Drugs | Prescribed Perspectives - McKesson
-
Senate Leaders Warn Defense Department About Procuring Generic Drugs Overseas - ProPublica
-
How We Created a Tool That Tells You Where Your Generic Drugs Were Made - ProPublica
-
ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs - ProPublica
-
“A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs - ProPublica
-
US is overly reliant on foreign-made generic drugs, warranting oversight, domestic investment, senators argue - McKnight's Long-Term Care News
-
Rx Inspector: ProPublica’s New Tool Provides Drug Info the FDA Won’t - ProPublica
-
As Wegovy patent ends in India, generic drugs flood a niche market - Nikkei Asia
-
FDA to pilot faster review of generic drugs manufactured in the US - European Pharmaceutical Review
-
Exclusive | Trump Excludes Generics From Big Pharma Tariff Plan - WSJ
-
US Onshoring Push for Generic Drugs - DCAT Value Chain Insights
-
Justices Told 'Skinny Label' Case Puts Generic Drugs At Risk - Law360
-
Cigna Unit Sells Generic Drugs at Higher Prices, Report Says - Bloomberg.com
-
Buy generic drugs in Idaho between 2009 and 2019? You could get money back - KBOI
-
States' Generic Drugs Antitrust Case Headed Toward Trial - Law360
-
Breaking Barriers: How Generic Drugs Democratize Mental Health - Frontiers
-
What are generic drugs and are they safe? - TBIJ
-
Rick Scott Wants Foreign-Made Generic Drugs to Have Country-of-Origin Labels - Floridian Press
-
Generic drugs account for 70% of treatments for patients in Romania, but the industry faces major challenges - Business Review
-
Generic Drugs Market Size to Reach USD 762.48 Billion by 2035 Driven by Rising Chronic Disease Burden and Cost-Control Focus - Yahoo Finance
-
Top generic drugs by prescriptions dispensed U.S - Statista
-
Securing a Healthier Future Through Generic Drugs - RealClearMarkets
-
Does the U.S. import a large share of generic prescription drugs from India? - CT Mirror
-
U.S. Generic Drugs Market Size to Reach USD 196.90 Billion By 2034 - BioSpace
-
Analysis of the physicians’ perception of original and generic drugs in Poland | Lewandowski | Arterial Hypertension - Via Medica Journals
-
Pharmaceutical 232 Must Cover Generic Drugs to Fulfill President’s Promise of Reshoring Essential Medicine Production - Coalition For A Prosperous America
-
UPDATED: Trump locks in 15% pharmaceutical tariff rate for EU, while generic drugs get a pass - Fierce Pharma
-
US FDA launches pilot program to fast-track review of domestically made generic drugs - Reuters
-
Generic Drugs Market Size to Worth USD 898 Billion by 2035, at a CAGR of 5.75% | Research by Vantage Market Research - PR Newswire
-
Senators Propose Sweeping Changes to Generic Drug Oversight - MedPage Today
-
Money for Tennesseans who bought prescription drugs - WDEF
-
Opinion | America invents these drugs. Why doesn’t it make them? - The Washington Post
-
Generic drugs revenue in prescribed drug market in India 2008-2020 - Statista
-
Senators expose US reliance on CCP-made generic drugs in bombshell report - Fox Business
-
ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs - ProPublica
-
Is Roche Poised for Growth After US Tariff Exemption on Generic Drugs? - Yahoo Finance
-
Seven Things to Know About ProPublica’s Investigation of the FDA’s Secret Gamble on Generic Drugs - ProPublica
-
Generic Drugs May Not Face Tariffs - Seeking Alpha
-
Why Won’t MDs and Pharmacists Believe You When Generic Drugs Fail? - The People's Pharmacy
-
The battle for GLP-1 generic drugs has begun, with Indian pharmaceutical companies immediately slashing prices by an order of magnitude. - 富途牛牛
-
GENERIC DRUGS—D.C. Cir.: Court upholds FDA’s approval of generic Entresto over Novartis challenge - VitalLaw.com
-
Lupin Share Price: US mein diabetes drugs launch, Stock **1.60%** up! Kya ye badhega? - Whalesbook
-
No US tariffs on generic drugs, for now; patented drugs face 100% tariffs, with caveats - BusinessLine
-
We Import Too Many Substandard Generic Drugs: Five Steps To Safety - Forbes
-
Generic Drugs Focused Amneal Pharmaceuticals Revenue Crosses $800 Million - Benzinga
-
Pharma stocks surge after Trump announces exemption for generic drugs from US tariffs - The American Bazaar
-
Does TrumpRx deliver the lowest drug prices? Why results are mixed. - USA Today
-
Trump Administration to Spare Generic Drugs from Tariff Plan, Report Says - INDIA New England News
-
Share of companies in the branded generic drugs market in the Philippines from 2007 to 2016, by type - Statista
-
Gilead Gets HIV Generic Drugs Barred From Market Until 2036 - Law360
-
Health Canada taking longer to approve generic drugs, data show - The Globe and Mail
-
Middle East and Africa Generic Drugs Market Size, 2033 - Market Data Forecast
-
Generic Drugs in Germany: New Opportunities in Germany Pharmaceutical Market - vocal.media
-
Where $2 prescription drug prices, Obamacare stand in Trump executive order onslaught - The Palm Beach Post
-
Insiders Expose Secrets: Generic Drugs, Big Pharma, Ads and Mail Order Meds - The People's Pharmacy
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India? - NDTV
-
ASHP Report: Some Generic Drugs A Persistent Source of Rx Shortages - Pharmacy Practice News
-
China releases 4th batch of encouraged generic drugs in 21 varieties - Global Times
-
South Africa Generic Drugs Market: Cost Efficiency, Accessibility Trends & Growth Outlook - vocal.media
-
Saudi Arabia Generic Drugs Market Outlook Report 2025-2033 - GlobeNewswire
-
How US tariffs could disrupt the generic drugs supply chain - SWI swissinfo.ch
-
Reliance on dangerous foreign generic drugs is killing Americans - The Hill
-
Generic Drugs Market Trend, Demand Analysis | CAGR of 5.0% - Market.us Media
-
White House shelves tariffs on generic drugs, sparing bitter pill for American patients and Indian pharma - The Times of India
-
Philippines Pharmaceutical Industry: Trends, Growth & Outlook - IMARC Group
-
Centre Engaging States to Promote Generic Drugs: MoS Health - Medical Dialogues
-
Zydus Lifesciences gets USFDA nod to market generic drugs - The Economic Times
-
Study finds no quality gap between branded and generic drugs; why pay 14x more? Says 'TheLiverDoc' - MSN
-
Corticosteroids - Inhalation & nasal spray generic drugs market outlook - Grand View Research
-
Tariff hits to generic drugs could 'blow back on everybody' without supply chain resilience, says USP chief - Fierce Pharma
-
Generic Drugs Recalled Due to Quality Issues - AARP
-
Wockhardt announces exit from generic drugs business in US - The Statesman
-
In a relief to Indian pharma industry, Trump administration withdraws tariffs on generic drugs - myind.net
-
OGD 2023 Annual Report - fda.gov
-
Unlocking The Full Potential Of Generic Drugs For Patients - Health Affairs
-
Zydus Lifesciences gets USFDA nod to market generic drugs - BusinessLine
-
U.S. Consumers Overpay for Generic Drugs - USC Schaeffer
-
Office of Generic Drugs 2022 Annual Report - fda.gov
-
Gluesenkamp Perez, Casten, Connolly Introduce Bill to Support Access to Lower-Priced Generic Drugs - House.gov
-
All generic drugs are not equal, study finds - Ohio State News
-
Antitrust Division | Generic Drugs Investigation Targets Anticompetitive Schemes - Department of Justice (.gov)
-
Office of Generic Drugs 2020 Annual Report - fda.gov
-
Clearing the Path for New Uses for Generic Drugs - Federation of American Scientists
-
AG Yost Secures $49.1 Million Settlement In Price-Fixing Cases Involving Generic Drugs - Ohio Attorney General (.gov)
-
Importing Generic Drugs Could Ease U.S. Shortages - Think Global Health
-
Hard questions remain about the quality of generic drugs in India - Scroll.in
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.